Peters, C M <br/><br/>
Endothelin and the tumorigenic component of bone cancer pain.  [electronic resource] 

 -  Neuroscience  2004 
 - 1043-52 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0306-4522 
<br/><br/><label>Standard No.: </label>10.1016/j.neuroscience.2004.04.027  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Analysis of Variance<br/>Animals<br/>Atrasentan<br/>Behavior, Animal<br/>Bone Neoplasms--complications<br/>Calcitonin Gene-Related Peptide--metabolism<br/>Disease Models, Animal<br/>Dynorphins--metabolism<br/>Endothelin Receptor Antagonists<br/>Endothelin-1--blood<br/>Ganglia, Spinal--metabolism<br/>Gene Expression Regulation, Neoplastic--drug effects<br/>Glial Fibrillary Acidic Protein--metabolism<br/>Immunohistochemistry--methods<br/>Male<br/>Mice<br/>Mice, Inbred Strains<br/>Pain--drug therapy<br/>Pain Measurement--drug effects<br/>Pyrrolidines--therapeutic use<br/>Receptors, Endothelin--metabolism<br/>Sarcoma--complications<br/>Sciatic Nerve--metabolism<br/>Time Factors